ADC Landscape Webinar
The momentum of ADCs has continued to assert its dominance in the oncology field throughout 2023, with a huge influx of new developers entering the space and numerous shifts in focus across payloads, combination trials, and Bispecific ADCs. In our recent webinar, we invited attendees to explore the traditional and novel ADC landscapes to maximize their pipelines and discover new opportunities that show huge potential to accelerate drug development.
We asked:
The total number of ADC programs has more than doubled in the last 2 years, what are the emerging trends from this recent influx of activity?
From Payloads, Linkers, and Targets, to Bispecifics and Combinations, which approaches are seeing the most use and having the most impact across the ADC space?
What were the key highlights and updates for ADC development across 2023?
Our Experts
Jia He
House Speaker
ADC Senior Research Lead
Beacon
Jake Morris
Moderator
Account Manager
Beacon
You May Also Be Interested In…
Novel Drug Conjugates and Clinical Success: An In-Depth Analysis of Emerging ADCs
Access Webinar
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
